Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.
Jiao Y, Davis JE, Rautela J, Carrington EM, Ludford-Menting MJ, Goh W, Delconte RB, Souza-Fonseca-Guimaraes F, Koldej R, Gray D, Huang D, Kile BT, Lew AM, Ritchie DS, Huntington ND. Jiao Y, et al. Among authors: ritchie ds. Cell Death Differ. 2019 Aug;26(8):1516-1530. doi: 10.1038/s41418-018-0228-y. Epub 2018 Nov 12. Cell Death Differ. 2019. PMID: 30420758 Free PMC article.
B cells in GVHD: friend or foe?
Davis JE, Ritchie DS. Davis JE, et al. Among authors: ritchie ds. Blood. 2010 Mar 25;115(12):2558-9; author reply 2559-60. doi: 10.1182/blood-2009-11-254177. Blood. 2010. PMID: 20339111 Free article. No abstract available.
Allogeneic transplantation as anticancer immunotherapy.
Parmar S, Ritchie DS. Parmar S, et al. Among authors: ritchie ds. Curr Opin Immunol. 2014 Apr;27:38-45. doi: 10.1016/j.coi.2014.01.010. Epub 2014 Feb 15. Curr Opin Immunol. 2014. PMID: 24534447 Review.
CD3bright signals on γδ T cells identify IL-17A-producing Vγ6Vδ1+ T cells.
Paget C, Chow MT, Gherardin NA, Beavis PA, Uldrich AP, Duret H, Hassane M, Souza-Fonseca-Guimaraes F, Mogilenko DA, Staumont-Sallé D, Escalante NK, Hill GR, Neeson P, Ritchie DS, Dombrowicz D, Mallevaey T, Trottein F, Belz GT, Godfrey DI, Smyth MJ. Paget C, et al. Among authors: ritchie ds. Immunol Cell Biol. 2015 Feb;93(2):198-212. doi: 10.1038/icb.2014.94. Epub 2014 Nov 11. Immunol Cell Biol. 2015. PMID: 25385067 Free article.
A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE, Harvey M, Gherardin NA, Koldej R, Huntington N, Neeson P, Trapani JA, Ritchie DS. Davis JE, et al. Among authors: ritchie ds. Biol Blood Marrow Transplant. 2015 Feb;21(2):242-9. doi: 10.1016/j.bbmt.2014.11.003. Epub 2014 Nov 12. Biol Blood Marrow Transplant. 2015. PMID: 25459639 Free article.
MicroRNA as potential biomarkers in Glioblastoma.
Areeb Z, Stylli SS, Koldej R, Ritchie DS, Siegal T, Morokoff AP, Kaye AH, Luwor RB. Areeb Z, et al. Among authors: ritchie ds. J Neurooncol. 2015 Nov;125(2):237-48. doi: 10.1007/s11060-015-1912-0. Epub 2015 Sep 21. J Neurooncol. 2015. PMID: 26391593 Review.
Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.
Neeson PJ, Hsu AK, Chen YR, Halse HM, Loh J, Cordy R, Fielding K, Davis J, Noske J, Davenport AJ, Lindqvist-Gigg CA, Humphreys R, Tai T, Prince HM, Trapani JA, Smyth MJ, Ritchie DS. Neeson PJ, et al. Among authors: ritchie ds. Oncoimmunology. 2015 May 27;4(9):e1038011. doi: 10.1080/2162402X.2015.1038011. eCollection 2015 Sep. Oncoimmunology. 2015. PMID: 26405606 Free PMC article.
240 results